Please note that slides are for review only and not to be repurposed or published.

DATA + PERSPECTIVES: EXPLORING THE ROLE OF NOVEL AGENTS AND EMERGING STRATEGIES IN THE MANAGEMENT OF ACUTE MYELOID LEUKEMIA

Introduction:
Dr Love

MODULE 1:
Evolving Paradigms in Up-Front Treatment for Older Patients or Those Ineligible for Intensive Chemotherapy — Dr Pollyea

MODULE 2:
Assessment, Incidence and Clinical Significance of FLT3 Mutations in AML — Dr Stone

MODULE 3:
Long-Term Treatment for Patients with AML with IDH Mutations — Dr Levis

MODULE 4:
Other Novel Agents and Promising Strategies Under Evaluation for Patients with AML — Prof Wei

Live Poll Results
Download

ADDRESSING CURRENT QUESTIONS AND CONTROVERSIES IN THE MANAGEMENT OF LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA (PART 1 OF A 2-PART SERIES)

Introduction:
Dr Love

MODULE 1:
Evolving Therapeutic Algorithms for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia (CLL) — Dr Kahl

MODULE 2:
Management of Relapsed/Refractory (R/R) CLL and Novel Investigational Approaches — Prof Gribben

MODULE 3:
Contemporary Management of Newly Diagnosed and R/R Follicular Lymphoma (FL) — Dr Cheson

MODULE 4:
Protocol and Off-Protocol Care for Patients with Mantle Cell Lymphoma (MCL) — Dr Abramson

MODULE 5:
Recent Breakthroughs and Other Promising Approaches in the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Sehn

MODULE 6:
Integration of CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy into the Management of Lymphomas — Dr Nastoupil

Live Poll Results
Download

ADDRESSING CURRENT QUESTIONS AND CONTROVERSIES IN THE MANAGEMENT OF MULTIPLE MYELOMA, AMYLOIDOSIS AND WALDENSTRÖM MACROGLOBULINEMIA (PART 2 OF A 2-PART SERIES)

Introduction:
Dr Love

MODULE 1:
Up-Front Management of Multiple Myeloma (MM) — Dr Raje

MODULE 2:
Consolidation and Maintenance Therapy; Emerging Role of Minimal Residual Disease (MRD) — Dr Munshi

MODULE 3:
Current Management of Relapsed/Refractory (R/R) MM — Dr Mateos

MODULE 41:
Novel Strategies Under Investigation for the Treatment of MM — Dr Lonial

MODULE 5:
Therapeutic Strategies Targeting B-Cell Maturation Antigen (BCMA) in MM — Dr Berdeja

MODULE 6:
Amyloidosis (AL) and Waldenström Macroglobulinemia (WM) — Dr Orlowski

Live Poll Results
Download